The angiotensin–converting enzyme inhibitor lisinopril is a commonly used antihypertensive and anti-proteinuric drug in humans, and is used as a reference drug when testing new compounds for the amelioration of diabetic nephropathy or CKD [14, 15]. This evidence concerns the gene ACE and chronic kidney disease.